The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events like heart attacks and strokes.
Source link
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal
Date:
Date:
The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events like heart attacks and strokes.
Source link